Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-077294
Filing Date
2022-07-05
Accepted
2022-07-05 16:02:14
Documents
2
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2220378-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2220378-4_4seq1.xml 4 4040
2 EXHIBIT 24.1 tm2220378d4_ex24-1.htm EX-24.1 5872
  Complete submission text file 0001104659-22-077294.txt   11419
Mailing Address C/O VASCULAR SOLUTIONS INC 6464 SYCAMORE COURT NORTH MINNEAPOLIS MN 55369
Business Address
NAGEL MICHAEL (Reporting) CIK: 0001213863 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39619 | Film No.: 221064740

Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Issuer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)